We are international
• about myeloma TEXT SIZE   
myeloma today    back

Spring 2005 Volume 6, Issue 4:
Update on Lenalidomide (CC-5013; Revlimid®)
By S. Vincent Rajkumar, MD
There has been intense research to develop a safer and more effective version of thalidomide. Lenalidomide (CC-5013; Revlimid®) is the first analog (close cousin) of thalidomide to enter clinical trials. It may prove to be more effective and safe

Be the first to comment

 related articles